Overview An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study Status: Active, not recruiting Trial end date: 2022-08-01 Target enrollment: Participant gender: Summary An Open-label, Randomized, 2-Period, Crossover Study to Assess the Comparative Pharmacokinetics of LSP-5415 and NuvaRing® in Healthy Adult Females Phase: Phase 2 Details Lead Sponsor: Lupin Research IncTreatments: EstradiolEthinyl EstradiolEtonogestrelNuvaRing